FDA Drug Application (202130) for TELMISARTAN by ALEMBIC PHARMS LTD

Back to FDA Applications sponsored by ALEMBIC PHARMS LTD

Application Number202130
Product Number001
FormTABLET;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTELMISARTAN
Active IngredientTELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by ALEMBIC PHARMS LTD